These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3012175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line.
    Yoshizaki T, Takimoto T, Takeshita H, Tanaka S, Furukawa M, Seiki M, Sato H.
    Laryngoscope; 1994 Jan; 104(1 Pt 1):91-4. PubMed ID: 8295464
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J, Steplewski Z, Weinmann R, Klein G, Koprowski H.
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [Abstract] [Full Text] [Related]

  • 8. Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines.
    Lin CT, Dee AN, Chen W, Chan WY.
    Lab Invest; 1994 Nov; 71(5):731-6. PubMed ID: 7967524
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome.
    Sato H, Takimoto T, Hatano M, Pagano JS, Raab-Traub N.
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():717-27. PubMed ID: 2543756
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z, Koprowski H, Andersson-Anvret M, Klein G.
    J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
    [Abstract] [Full Text] [Related]

  • 12. Differences in the ability of cells to fuse are mediated by strains of Epstein-Barr virus.
    Takimoto T, Sato H, Ogura H, Tanaka S, Masuda K, Ishikawa S, Umeda R.
    Laryngoscope; 1989 Oct; 99(10 Pt 1):1075-80. PubMed ID: 2552238
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T, Endo K, Ren Q, Wakisaka N, Murono S, Kondo S, Sato H, Furukawa M.
    Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 15. In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes.
    Desgranges C, Lenoir G, de-Thé G, Seigneurin JM, Hilgers J, Dubouch P.
    Biomedicine; 1976 Dec 05; 25(9):349-52. PubMed ID: 187263
    [Abstract] [Full Text] [Related]

  • 16. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
    Lin CT, Chen W, Hsu MM, Dee AN.
    Lab Invest; 1997 Jun 05; 76(6):793-8. PubMed ID: 9194855
    [Abstract] [Full Text] [Related]

  • 17. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T, Umeda R, Glaser R.
    Acta Virol; 1989 Aug 05; 33(4):375-7. PubMed ID: 2574946
    [Abstract] [Full Text] [Related]

  • 18. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun 05; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus and nasopharyngeal carcinoma.
    Raab-Traub N.
    Semin Cancer Biol; 1992 Oct 05; 3(5):297-307. PubMed ID: 1335793
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May 05; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.